申请人:Warner-Lambert Company
公开号:US05153226A1
公开(公告)日:1992-10-06
The present invention are novel amino acid amide compounds of the following general formula which inhibit the enzyme acylcoenzyme A:cholesterol acyltransferase: ##STR1## wherein R is phenyl or 1- or 2-naphthyl which are unsubstituted or may be substituted; R.sub.1 is hydrogen or a straight or branched alkyl group having from 1 to 6 carbon atoms; R.sub.2 is hydrogen, an aliphatic group, an aromatic group, an aralkyl or diarylalkyl group or R.sub.1 and R.sub.2 form a carbocyclic group; R.sub.3 is hydrogen, an aliphatic group, an aralkyl group wherein the alkyl moiety may contain a carbocyclic entity; R.sub.4 is hydrogen, an aliphatic group, SO.sub.2 R.sub.14, --C(.dbd.S)NHR.sub.15, --CO.sub.2 R.sub.15, --COR.sub.18, or --C(.dbd.O)NHR.sub.15 wherein R.sub.14 is morpholino, phenyl or substituted phenyl; R.sub.15 is an alkyl group, phenyl or phenylalkyl wherein the phenyl group may be substituted; and R.sub.18 is the same is R.sub.15 or is halo-substituted alkyl, 9-fluoroenylmethylene or pyrrolidino.
本发明是以下通式的新型氨基酸酰胺化合物,可以抑制酶酰辅酶A:胆固醇酰基转移酶的活性:
其中R是苯基或未取代或可取代的1-或2-萘基;R1是氢或含有1至6个碳原子的直链或支链烷基基团;R2是氢、脂肪基、芳香基、芳基烷基或双芳基烷基基团,或者R1和R2形成一个环烷基基团;R3是氢、脂肪基、芳基烷基,其中烷基基团可能含有一个环烷基实体;R4是氢、脂肪基、SO2R14、--C(.dbd.S)NHR15、--CO2R15、--COR18,或--C(.dbd.O)NHR15,其中R14是吗啉基、苯基或取代苯基;R15是烷基基团、苯基或苯基烷基,其中苯基可能被取代;R18与R15相同或是卤代烷基、9-氟烯基甲基或吡咯烷基。